:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Carlos Cruz‐Cortés, Eli Fernández‐de Gortari, Rodrigo Aguayo‐Ortiz, Jaroslava Šeflová, Adam Ard, Martin Clasby, Justus Anumonwo, L. Michel Espinoza‐Fonseca
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	ChemMedChem
Accesso online:	https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202400913
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Small‐Molecule Sarco/Endoplasmic Reticulum Ca 2+ ‐ATPase Activators Reverse Methylglyoxal‐Induced Inhibition through Nonantioxidant Mechanisms
di: Carlos Cruz‐Cortés, et al.
Pubblicazione: (2025)

Glyoxalase‐1 Inhibition Leads to Ferroptosis Induction in Lung Cancer Cells: A Dual Mechanism of Action of Hydroxamic Acids Derived from Cysteine
di: Josué Martínez‐Miranda, et al.
Pubblicazione: (2025)

Structure–Property Associations: Breaking Paradigms for Linking Chemical Structures and Biological Properties in Drug Discovery
di: Edgar López‐López, et al.
Pubblicazione: (2025)

Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer Agents
di: Nishant M. Karadkhelkar, et al.
Pubblicazione: (2024)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
di: Alisa Heuser, et al.
Pubblicazione: (2024)

Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe
di: Hao Lin, et al.
Pubblicazione: (2024)

Discovery of Palindrome Dual PPARγ‐GPR40 Agonists for Treating Type 2 Diabetes
di: Ana Rodríguez‐Luévano, et al.
Pubblicazione: (2024)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
di: Ilaria Cursaro, et al.
Pubblicazione: (2024)

C9‐Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α‐Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration
di: Clémence Rose, et al.
Pubblicazione: (2024)

Addressing Data Point Homogeneity and Annotation Challenges to Enhance Data‐Driven Approaches: The S. aureus NorA Efflux Pump Case Study
di: Andrea Astolfi, et al.
Pubblicazione: (2025)

Naturally Occurring and Widespread Resistance to Bioactive Natural Products
di: Bin Tan, et al.
Pubblicazione: (2024)

Accelerating Drug Discovery through Knowledge Sharing
di: Rory C. McAtee
Pubblicazione: (2026)

Quinoline‐ and Pyrimidine‐based Allosteric Modulators of the Sarco/Endoplasmic Reticulum Calcium ATPase
di: Stefan Paula, et al.
Pubblicazione: (2024)

“Cofactors” for Natural Products
di: Shao‐Lun Chiou, et al.
Pubblicazione: (2025)

Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
di: Isabelle Lyothier, et al.
Pubblicazione: (2025)

Current Approaches and Strategies Applied in First‐in‐class Drug Discovery
di: Idrees Mohammed, et al.
Pubblicazione: (2024)

Discovery of New CDDO‐Imidazole Derivatives as Potential Antitumor Agents
di: Yanqing Li, et al.
Pubblicazione: (2026)

From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
di: Mehmet Ali Yucel, et al.
Pubblicazione: (2024)

A New Series of Amino Alcohol Oxime Ethers as Activators of Human Brain Carbonic Anhydrases: Advances in Selective Activation of Human Carbonic Anhydrase VII
di: Camilla Mangini, et al.
Pubblicazione: (2026)

In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
di: Frankie S. Mak, et al.
Pubblicazione: (2026)

Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
di: Ariane F. Hübner, et al.
Pubblicazione: (2026)

Drug Discovery Summit: 14 th Swiss Course on Medicinal Chemistry
di: Céline Schuppisser, et al.
Pubblicazione: (2024)

Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9
di: Philipp Grosche, et al.
Pubblicazione: (2024)

Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
di: Jieye Lin, et al.
Pubblicazione: (2025)

Fluorescence‐Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines
di: Jan Voldřich, et al.
Pubblicazione: (2024)

Nucleic Acid Materials‐Mediated Innate Immune Activation for Cancer Immunotherapy
di: Xinyu Xu, et al.
Pubblicazione: (2024)

Natural Staurosporine Derivatives with Fluorescence for Cancer Theranostics
di: Kualiang Li, et al.
Pubblicazione: (2025)

Biosynthesis of Natural and Unnatural Perylenequinones for Drug Development
di: Zengping Su, et al.
Pubblicazione: (2024)

AgamOBP1‐Directed Discovery of Repellents to Control the Spread of Mosquito‐Borne Diseases
di: Evanthia Chazapi, et al.
Pubblicazione: (2025)

Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits
di: Sabrina Silva‐Mendonça, et al.
Pubblicazione: (2026)

Discovery of ICOS‐Targeted Small Molecules Using Affinity Selection Mass Spectrometry Screening
di: Longfei Zhang, et al.
Pubblicazione: (2024)

Phenotypic‐Based Discovery and Exploration of a Resorufin Scaffold with Activity against Mycobacterium tuberculosis
di: Eric Tran, et al.
Pubblicazione: (2024)

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
di: Tim Kirkman, et al.
Pubblicazione: (2024)

Discovery of Novel Fluorescent Azaindoles with Cytotoxic Action in A2780 Ovarian Carcinoma Cells
di: José C. Cunha, et al.
Pubblicazione: (2024)

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites
di: Anne Robert, et al.
Pubblicazione: (2025)

Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)
di: K. Jagathesan, et al.
Pubblicazione: (2024)

A Nitroreductase‐Activatable Lapachol Against Bacillus subtilis Unveils Antimicrobial Specificity
di: Ivonne R. Lopez‐Miranda, et al.
Pubblicazione: (2026)

Recent Developments On Activatable Turn‐On Fluorogenic Donors of Hydrogen Sulfide (H2S)
di: Roopjyoti Misra, et al.
Pubblicazione: (2024)

Natural Distribution, Structures, Synthesis, and Bioactivity of Hasubanan Alkaloids
di: Yingjie Wang, et al.
Pubblicazione: (2024)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
di: Jochem Nelen, et al.
Pubblicazione: (2026)